|
Shareholders' Equity
|
12 Months Ended |
|---|---|
|
Dec. 31, 2014
|
|
| Equity [Abstract] | |
| Stockholders' Equity | SHAREHOLDERS' EQUITY In connection with the Spin-off, each of the shareholders of Exelis received one share of Vectrus common stock for every eighteen shares of common stock of Exelis held on the Record Date resulting in the distribution of 10.5 million shares of common stock to Exelis shareholders. As of December 31, 2014, our authorized capital was comprised of 100.0 million shares of common stock and 10.0 million shares of preferred stock. At December 31, 2014, there were 10.5 million shares of common stock issued and outstanding. No preferred stock was issued and outstanding at December 31, 2014. We issue shares of our common stock in connection with our 2014 Omnibus Plan. At December 31, 2014, 2.6 million shares of common stock were reserved for issuance in connection with this Plan and we had a remaining balance of 1.7 million shares of common stock available for future grants under this plan. Any shares related to awards that terminate by (i) expiration, (ii) forfeiture, (iii) cancellation, (iv) settling in cash in lieu of shares or otherwise without the issuance of such shares, (v) or are exchanged with the Committee's permission for awards not involving shares are available again for grant under the 2014 Omnibus Plan. |